Saccharomyces boulardii CNCM I-745 Improves Intestinal Enzyme Function: A Trophic Effects Review
Authors:
Open Access
- 1 January 2018
- journal article
- review article
- Published by SAGE Publications in Clinical Medicine Insights: Gastroenterology
- Vol. 11
Abstract
Several properties of the probiotic medicinal yeast Saccharomyces boulardii CNCM I-745 contribute to its efficacy to prevent or treat diarrhoea. Besides immunologic effects, pathogen-binding and anti-toxin effects, as well as positive effects on the microbiota, S boulardii CNCM I-745 also has pronounced effects on digestive enzymes of the brush border membrane, known as trophic effects. The latter are the focus of this review. Literature has been reviewed after searching Medline and PMC databases. All relevant non-clinical and clinical studies are summarized. S. boulardii CNCM I-745 synthesizes and secretes polyamines, which have a role in cell proliferation and differentiation. The administration of polyamines or S. boulardii CNCM I-745 enhances the expression of intestinal digestive enzymes as well as nutrient uptake transporters. The signalling mechanisms leading to enzyme activation are not fully understood. However, polyamines have direct nucleic acid–binding capacity with regulatory impact. S. boulardii CNCM I-745 induces signalling via the mitogen-activated protein kinase pathway. In addition, effects on the phosphatidylinositol-3 kinase (PI3K) pathway have been reported. As an additional direct effect, S. boulardii CNCM I-745 secretes certain enzymes, which enhance nutrient acquisition for the yeast and the host. The increased availability of digestive enzymes seems to be one of the mechanisms by which S. boulardii CNCM I-745 counteracts diarrhoea; however, also people with certain enzyme deficiencies may profit from its administration. More studies are needed to fully understand the mechanisms of trophic activation by the probiotic yeast.Keywords
This publication has 96 references indexed in Scilit:
- Raf: A key regulatory kinase for transduction of mitogenic and metabolic signals of the probiotic Saccharomyces boulardiiClinics and Research in Hepatology and Gastroenterology, 2011
- Protein kinase CK2 links polyamine metabolism to MAPK signalling in DrosophilaCellular Signalling, 2011
- Current Status of the Polyamine Research Field2011
- Interaction of Saccharomyces boulardii with Salmonella enterica Serovar Typhimurium Protects Mice and Modifies T84 Cell Response to the InfectionPLOS ONE, 2010
- Modulation of cellular function by polyaminesThe International Journal of Biochemistry & Cell Biology, 2010
- Polyamine catabolism and diseaseBiochemical Journal, 2009
- Twenty-Five Years of Research on Saccharomyces boulardii Trophic Effects: Updates and PerspectivesDigestive Diseases and Sciences, 2008
- Polyamine analogues – an updateAmino Acids, 2007
- Genotypic and Physiological Characterization of Saccharomyces boulardii , the Probiotic Strain of Saccharomyces cerevisiaeApplied and Environmental Microbiology, 2007
- Enzyme-Substitution Therapy with the YeastSaccharomyces cerevisiaein Congenital Sucrase-Isomaltase DeficiencyNew England Journal of Medicine, 1987